Szczypka MS, Westover AJ, Clouthier SG, Ferrara JLM, and Humes HD. Rare incorporation of bone marrow-derived cells into kidney after folic acid-induced injury. Stem Cells 2004. (In press.)

Szczypka MS and Humes HD. Stem cells and the kidney. In: Handbook of Stem Cells. San Diego: Elsevier. (In press.)

Low J, Humes HD, Szczypka M, and Imperiale M. BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology 2004;323(2):182–188.

Humes HD, Weitzel WF, Fissell WH. Renal cell therapy in the treatment of patients with acute and chronic renal failure. Blood Purif 2004;22:60–72.

Humes HD, Weitzel WF, Bartlett RH, Swaniker FC, Paganini EP, Luderer JR, and Sobota J. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 2004;66:1578–1588.

Humes HD and Szczypka MS. Advances in cell therapy for renal failure. Transplant Immunology 2004;12:219–227.

Fissell WH and Humes HD. Cell therapy of renal failure. Transplant Proc 2003;35:2837–2842.

Humes HD. Cell therapy: Leveraging nature’s therapeutic potential. J Am Soc Nephrol 2003;14:2211–2213.

Humes HD, Buffington DA, Lou L, Abrishami S, Wang M, Xia J, and Fissell WH. Cell therapy with a tissue-engineered kidney protects against the multi-organ consequences of septic shock. Crit Care Med 2003;31:2421–2428.

Humes HD, Weitzel WF, Bartlett RH, Swaniker FC, and Paganini EP. Renal cell therapy is associated with dynamic and individualized responses in patients with acute renal failure. Blood Purif 2003;21:64–71.

Fissell WH, Lou L, Abrishami S, Buffington DA, and Humes HD. Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals. J Am Soc Nephrol 2003;14:454-461.

Humes HD, Fissell WH, and Weitzel WF. The bioartificial kidney in the treatment of acute renal failure. Kidney Int 2002;61(Suppl 80):S121–S125.

Fissell WH, Dyke DB, Buffington DA, Weitzel WF, Westover AJ, MacKay SM, Gutierrez JM, and Humes HD. Bioartificial kidney alters cytokine response and hemodynamics in endotoxin-challenged dogs. Blood Purif 2002;20:55–60.

Humes HD, Fissell WH, Weitzel WF, Buffington DA, Westover AJ, MacKay SM, and Gutierrez JM. Metabolic replacement of renal function in uremic animals with a bioartificial kidney containing human cells. Am J Kidney Dis 2002;39(5):1078–1087.

Recent Presentations

2004

Speaker, 6th International Conference on Dialysis: Advances in ESRD 2004, Renal Research Institute and University of Minnesota; Rio Grande, Puerto Rico

Speaker, 9th International Conference on Continuous Renal Replacement Therapies, San Diego

Keynote Speaker, Combined Meeting of the Chicago Pathology Society and the Chicago Section of the American Association for Clinical Chemistry, Chicago

Speaker, Whitney Symposium 2004—Bionics, GE Global Research Center, Niskayuna, New York

2003

Visiting Professor, Brown University

Speaker, International Conference on Dialysis V: Advances in ESRD 2003, Renal Research Institute and University of Minnesota, Miami Beach

Speaker, 8th International Conference on Continuous Renal Replacement Therapies, San Diego

Visiting Professor, University of Maryland

Speaker, Engineering Tissue Growth International Conference and Exposition, Pittsburgh Tissue Engineering Initiative, Pittsburgh

Visiting Professor, University of Wisconsin

Speaker, Joint Conference of the American Society for Artificial Organs and the International Society for Artificial Organs, Washington, DC

Speaker, International Symposium on the Surgical Treatment of Uremia: From Renal Transplant to the Implantable Artificial Kidney, Fundación Ramon Areces, Madrid

Distinguished Lectureship, Rochester General Hospital Teaching Foundation, University of Rochester

Speaker, American Society of Nephrology Annual Meeting, San Diego

Visiting Professor, Winthrop University Hospital and State University of New York at Stony Brook

Visiting Consultant, Northwestern University

2002

Speaker, International Conference on Dialysis IV: Advances in ESRD 2002, Renal Research Institute and University of Minnesota, Phoenix

Visiting Professor, Emory University

Visiting Professor, William Beaumont Hospital, Royal Oak, Michigan

Co-chair, Symposium on Post-Operative Acute Renal Failure; Speaker, Symposium on Emerging Research in Extracorporeal Support and Symposium on Looking to the Future: Assessing and Applying New Technology; 7th International Conference on Continuous Renal Replacement Therapies, San Diego

Speaker, 2nd Annual Engineering Tissue Growth International Conference & Exhibition, Pittsburgh Tissue Engineering Initiative, Pittsburgh

Visiting Professor, State University of New York Downstate Medical Center

Visiting Professor, Oakwood Hospital and Medical Center, Dearborn, Michigan

Speaker, Update in ICU Medicine and its Impact on Nephrology, National Kidney Foundation Clinical Nephrology Meetings, Chicago

Visiting Professor, University of South Carolina

Speaker, 16th Portuguese Congress of Nephrology, Estoril

Speaker, Symposium on New Technology in Hemodialysis; Comoderator, Renal Slide Forum; 48th Annual Conference & Exposition of the American Society for Artificial Internal Organs, New York

Speaker, Stem Cell Technologies in Regenerative Medicine, IIR Life Sciences, London

Chair and moderator, Scientific Session on Regenerative Medicine, Combined Annual Meeting, Central Society for Clinical Research, Chicago

Speaker, Post-graduate Education Course on Hemodialysis; Speaker, Clinical Nephrology Conference on the Changing Spectrum of Acute Renal Failure in the ICU; American Society of Nephrology Annual Meeting, Philadelphia

Speaker, 3rd Annual Conference on Regenerative Medicine: The New Medicine—From Repair to Regeneration, Genetic Engineering News and The Society of Regenerative Medicine, Washington, D.C.